Drug Trial Radar · NCT01000025
PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer
Last checked: Nov 20, 2026Latest source record: Aug 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
720
Actual
Start
Dec 23, 2009
Primary completion
Jan 15, 2014
Study completion Nov 27, 2015
Sponsor
- Lead sponsor
- NCIC Clinical Trials GroupResearch network
- Sponsor type
- Research network
- Collaborators
- Pfizer
- First posted
- Oct 22, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: PF-00299804 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether PF-00299804 is more effective than a placebo in treating patients with advanced non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying PF-00299804 to see how well it works compared with a placebo in treating patients with stage IIIB or stage IV non-small cell lung cancer that has not responded to standard therapy for advanced or metastatic cancer.
Conditions
- Lung Cancer
Interventions
PF-00299804Drug
PF-804 45 mg PO, daily
PlaceboDrug
Placebo 45 mg PO, daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: 42 Months
Locations
89 sites in 12 countries. Site status is shown where the registry gives one.
Shapiro, Stafford and Yee
Arcadia, California
Clintell, Inc.
Skokie, Illinois
Damic-Fundacion Rusculleda
Córdoba, Argentina
Centro Medico San Roque
San Miguel de Tucumán, Argentina
CER - Instituto Medico
Buenos Aires, B1878dvb Bs. As., Argentina
COIBA Centro de Oncologia e Investigacion
Berazategui, Buenos Aires, Argentina
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Concord Repatriation General Hospital
Concord, New South Wales, Australia
St. George Hospital, Cancer Care Centre
Kogarah, New South Wales, Australia
Prince of Wales Hospital
Randwick, New South Wales, Australia
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
The Prince Charles Hospital
Chermside, Queensland, Australia
Nambour General Hospital
Nambour, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Monash Medical Centre
Clayton, Victoria, Australia
Western Hospital
Footscray, Victoria, Australia
Frankston Hospital - Peninsula Oncology Centre
Frankston, Victoria, Australia
Geelong Hospital
Geelong, Victoria, Australia
Austin Hospital
Heidelberg, Victoria, Australia
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
Oxion Hospital Dia Oncologia LTDA - Oxion
Belo Horizonte, Brazil
Site not named
Centro, Brazil
Nucleo de Oncologia da Bahia
Salvador, Brazil
GRAM - Grupo de Assistencia Medica
São Paulo, Brazil
Centro de Oncologia e Radioterapia (COR) Mae de Deus
Porto Alegre, Rio Grande do Sul, Brazil
Fundacao Pio XII - Hospital de Cancer de Barretos
Barretos, São Paulo, Brazil
ESHO - Empresa de Servicos Hospitalares Ltda.
Brasilia, São Paulo, Brazil
Centro de Pesquisa Clinica do Hospital
Porto Alegre, São Paulo, Brazil
Cross Cancer Institute
Edmonton, Alberta, Canada
BCCA - Abbotsford Centre
Abbotsford British Columbia, British Columbia, Canada
BCCA - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
BCCA - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Health Sciences North
Greater Sudbury, Ontario, Canada
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.